ARCHIVES

In Brief: Reorganization Package Wending Its Way Through The Bureaucracy; FDA Seeks Names for Committee

This article is from The Cancer Letter archive.

Vol. 05 No. 48 | November 30, 1979

Download PDF Visit The Full Archive

Related Articles

IOM Report Calls For FDA Authority Nutritional Supplement Health Claims

May 21, 2010

Bunn Says ASCO Is “Strong, Diverse, Respected, Growing”

June 6, 2003

In Congress: Tamoxifen Results Well Communicated, Understood, NCI Says

May 1, 1998

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989

Shubik Group Finally Completes Document On Carcinogenicity Criteria

March 12, 1976